Ardea Biosciences Announces Exercise in Full of Overallotment Option for …
SAN DIEGO, Feb. 23, 2011 /PRNewswire/ — Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 412500 …
See all stories on this topic »